Raymond James & Associates’s Skylight Health Group Inc Common Shares SLHG Stock Holding History

Raymond James & Associates’s Portfolio SLHG Stock Details SLHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-85,293	Closed	-$41K	–	4203
2022 Q2	$41K	Hold	85,293	–	–	﹤0.01%	3813
2022 Q1	$90K	Buy	+85,293	New	+$86K	﹤0.01%	3845

Raymond James & Associates's SLHG Position: Q3 2022 in Review

Raymond James & Associates sold out of Skylight Health Group Inc Common Shares (SLHG) in Q3 2022, closing a stake of 85,293 shares — an estimated $41K sold.

Raymond James & Associates first reported a position in SLHG in Q1 2022 and held it in 2 quarters. The position peaked at $90K in Q1 2022. 0 funds tracked by Wall St. Rank hold SLHG as of Q3 2022.

Raymond James & Associates reported no remaining Skylight Health Group Inc Common Shares position as of Q3 2022 after selling out during the quarter.
Raymond James & Associates sold 85,293 Skylight Health Group Inc Common Shares shares in Q3 2022, an estimated $41K.
Raymond James & Associates first reported a position in Skylight Health Group Inc Common Shares in Q1 2022 and held it in 2 quarters.
Raymond James & Associates's Skylight Health Group Inc Common Shares position peaked at $90K in Q1 2022.
0 funds tracked by Wall St. Rank held Skylight Health Group Inc Common Shares as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.